Electrical stimulation of nucleus paragigantocellularis induces opioid withdrawal-like behaviors in the rat

Pharmacology Biochemistry and Behavior

Volumn 62, Issue 2, 1999, Pages 263-271

  Liu, Niansen ^a   Rockhold, Robin W ^a   Ho, Ing K ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Behavior; Butorphanol dependence; Nucleus paragigantocellularis; Opioid antagonists; Opioid withdrawal

Indexed keywords

BETA FUNALTREXAMINE; BUTORPHANOL; DELTA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NALOXONE; NALTRINDOLE; NORBINALTORPHIMINE; OPIATE ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BRAIN NUCLEUS; CONTROLLED STUDY; DRUG WITHDRAWAL; ELECTROSTIMULATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BEHAVIOR, ANIMAL; ELECTRIC STIMULATION; MALE; MEDULLA OBLONGATA; NARCOTIC ANTAGONISTS; NEURONS; OPIOID-RELATED DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0032929791     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00164-6     Document Type: Article

References (49)

1. Aghajanian G.K. Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature. 276:1978;186-188.
2. Aghajanian G.K., Alreja M., Nestler E.J., Kogan J.H. Dual mechanisms of opiate dependence in the locus coeruleus. Clin. Neuropharmacol. 15(Suppl. 1):1992;143A-144A.
3. Akaoka H., Aston-Jones G. Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input. J. Neurosci. 11:1991;3830-3839.
4. Andrade R., VanderMaelen C.P., Aghajanian G.K. Morphine tolerance and dependence in the locus coeruleus. Single cell studies in brain slices Eur. J. Pharmacol. 91:1983;161-169.
5. Andrezik J.A., Chan-Palay V., Palay S.L. The nucleus paragigantocellularis lateralis in the rat. Conformation and cytology Anat. Embryol. 161:1981;355-371.
6. Aston-Jones G., Ennis M., Pieribone V.A., Nickell W.T., Shipley M.T. The brain nucleus locus coeruleus. Restricted afferent control of a broad afferent network Science. 234:1986;734-736.
7. Aston-Jones G., Shipley M.T., Chouvet G., Ennis M., Van Bockstaele E.J., Pieribone V., Shiekhattar R., Akaoka H., Drolet G., Astier B., Charlety P., Valentino R., Williams J.T. Afferent regulation of locus coeruleus neurons. Anatomy, physiology and pharmacology Prog. Brain Res. 88:1991;47-75.
8. Beaulieu J., Champagne D., Drolet G. Enkephalin innervation of the paraventricular nucleus of the hypothalamus. Distribution of fibers and origins of input J. Chem. Neuroanat. 10:1996;79-92.
9. Bozarth M.A. Opioid reinforcement processes. Rodgers R.J., Cooper S.J. Endorphins, opiates and behavioral processes. 1988;53 John Wiley and Sons, Ltd, London.
10. Calvino B., Lagowska J., Ben-Ari Y. Morphine withdrawal syndrome. Differential participation of structures located within the amygdaloid complex and striatum of the rat Brain Res. 177:1979;19-34.
11. Christie M.J., Williams J.T., Osborne P.B., Bellchambers C.E. Where is the locus in opioid withdrawal? Trends Pharmacol. Sci. 18:1997;134-140.
12. Dauge V., Rossignol P., Roques B.P. Comparison of the behavioural effects induced by administration in rat nucleus accumbens or nucleus caudatus of selective mu and delta opioid peptides or kelatorphan an inhibitor of enkephalin-degrading-enzymes. Psychopharmacology (Berlin). 96:1988;343-352.
13. Dauge V., Rossignol P., Roques B.P. Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the nucleus caudatus but not in the nucleus accumbens. Differential involvement of delta and mu receptors Psychopharmacology (Berlin). 99:1989;168-175.
14. Ennis M., Aston-Jones G. Activation of locus coeruleus from nucleus paragigantocellularis. A new excitatory amino acid pathway in brain J. Neurosci. 8:1988;3644-3657.
15. Feng Y.Z., Narita M., Tseng Y.T., Hoskins B., Ho I.K. Cross-tolerance between butorphanol and morphine in rats. Pharmacol. Biochem. Behav. 49:1994;657-661.
16. Feng Y.Z., Tseng Y.T., Jaw S.P., Hoskins B., Ho I.K. Tolerance development to butorphanol. Comparison with morphine Pharmacol. Biochem. Behav. 49:1994;649-655.
17. Feng Y.Z., Zhang T., Rockhold R.W., Ho I.K. Opioid receptor subtypes modulate pontine excitatory amino acid (EAA) levels differently in butorphanol and morphine dependence. Soc. Neurosci. Abstr. 20:1994;1232.
18. Feng Y.Z., Zhang T., Tokuyama S., Zhu H., Rockhold R.W., Ho I.K. Mu and delta opioid receptor antagonists precipitate similar withdrawal phenomena in butorphanol and morphine dependence. Neurochem. Res. 21:1996;63-71.
19. Foote S.L., Bloom F.E., Aston-Jones G. Nucleus locus coeruleus. New evidence of anatomical and physiological specificity Physiol. Rev. 63:1983;844-914.
20. Fort P., Luppi P.H., Sakai K., Salvert D., Jouvet M. Nuclei of origin of monoaminergic, peptidergic, and cholinergic afferents to the cat trigeminal motor nucleus. A double-labeling study with cholera-toxin as a retrograde tracer J. Comp. Neurol. 301:1990;262-275.
21. Grant S.J., Huang Y.H., Redmond D.E. Jr. Behavior of monkeys during opiate withdrawal and locus coeruleus stimulation. Pharmacol. Biochem. Behav. 30:1988;13-19.
22. Horan P., Ho I.K. The physical dependence liability of butorphanol. A comparative study with morphine Eur. J. Pharmacol. 203:1991;387-391.
23. Jaw S.P., Makimura M., Oh K.W., Hoskins B., Ho I.K. Involvement of kappa-opioid receptors in opioid dependence/withdrawal. Studies using butorphanol Eur. J. Pharmacol. 257:1994;153-160.
24. Kennes D., Odberg F.O., Bouquet Y., De Rycke P.H. Changes in naloxone and haloperidol effects during the development of captivity-induced jumping stereotypy in bank voles. Eur. J. Pharmacol. 153:1988;19-24.
25. Kogan J.H., Nestler E.J., Aghajanian G.K. Elevated basal firing rates and enhanced responses to 8-Br-cAMP in locus coeruleus neurons in brain slices from opiate-dependent rats. Eur. J. Pharmacol. 211:1992;47-53.
26. Lindenmayer J.-P., Gardner E., Goldberg E., Opler L.A., Kay S.R., van Praag H.M., Weiner M., Zukin S. High-dose naloxone in tardive dyskinesia. Psychol. Res. 26:1988;19-28.
27. Maldonado R., Stinus L., Gold L.H., Koob G.F. Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol. Exp. Ther. 261:1992;669-677.
28. Maldonado R., Koob G.F. Destruction of the locus coeruleus decreases physical signs of opiate withdrawal. Brain Res. 605:1993;128-138.
29. Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., Gilbert P.E. The effects of morphine and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197:1976;517-532.
30. Monkovic I., Conway T.T., Wong H., Perron T.G., Pachter I.J., Belleau B. Total synthesis and pharmacological activities of N-substituted 3,14-dihydroxymorphinans. J. Am. Chem. Soc. 95:1973;7910-7916.
31. Oh K.W., Makimura M., Jaw S.P., Hoskins B., Ho I.K. Effects of beta-funaltrexamine on butorphanol dependence. Pharmacol. Biochem. Behav. 42:1992;29-34.
32. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 2:1986;Academic Press, Sydney.
33. Pollock J., Kornetsky C. Naloxone prevents and blocks the emergence of neuroleptic-mediated oral stereotypic behaviors. Neuropsychopharmcology. 4:1991;245-249.
34. Punch L.J., Self D.W., Nestler E.J., Taylor J.R. Opposite modulation of opiate withdrawal behaviors on microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray. J. Neurosci. 17:1997;8520-8527.
35. Rasmussen K., Aghajanian G.K. Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats. Attenuation by lesions of the nucleus paragigantocellularis Brain Res. 505:1989;346-350.
36. Rasmussen K., Beitner-Johnson D.B., Krystal J.H., Aghajanian G.K., Nestler E.J. Opiate withdrawal and the rat locus coeruleus. Behavioral, electrophysiological and biochemical correlates J. Neurosci. 10:1990;2308-2317.
37. Rasmussen K. Afferent effects on locus coeruleus in opiate withdrawal. Prog. Brain Res. 88:1991;207-216.
38. Rasmussen K. The role of the locus coeruleus and N-methyl-D-aspartic acid (NMDA) and AMPA receptors in opiate withdrawal. Neuropsychopharmacology. 13:1995;295-300.
39. Redmond D.E. Jr., Huang Y.H., Snyder D.R., Maas J.W. Behavioral effects of stimulation of the locus coeruleus in the stump-tailed monkey (Macaca arctoides). Brain Res. 116:1976;502-510.
40. Redmond D.E. Jr., Krystal J.H. Multiple mechanisms of withdrawal from opioid drugs. Annu. Rev. Neurosci. 7:1984;443-478.
41. Rockhold, R. W.; Liu, N.; Sinchaisuk, S.; Ho, I. K.: Electrical stimulation of nucleus paragigantocellularis (PGi) and evocation of opioid withdrawal-like behavior. Proceedings of the 13th IUPHAR Meetings, Munich, Germany; 1998.
42. Roques B.P., Dauge V., Gacel G., Fournie-Zaluski M.C. Selective agonists and antagonists of delta opioid receptors and inhibitors of enkephalin metabolism. Potential use in treatment of mental illness Shagass C., Josiassen R.C., Bridger W.H., Weiss K.J., Stoff D., Simpson G.M. Developments in psychiatry, vol. 7, Biological psychiatry 1985. 1985;287-289 Elsevier, New York.
43. Stoessl A.J., Polanski E., Frydryszak H. The opiate antagonist naloxone suppresses a rodent model of tardive dyskinesia. Move. Disord. 8:1993;445-452.
44. Tempel A., Zukin R.S. Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography. Proc. Natl. Acad. Sci. USA. 84:1987;4308-4312.
45. Valentino R.J., Aston-Jones G. Physiological and anatomical determinants of locus coeruleus discharge. Bloom F.E., Kupfer D.J. Psychopharmacology. The fourth generation of progress:1995;373-385 Raven Press, Ltd, New York.
46. Valentino R.J., Wehby R.G. Morphine effects on locus coeruleus neurons are dependent on the state of arousal and availability of external stimuli. Studies in anesthetized and unanesthetized rats J. Pharmacol. Exp. Ther. 244:1988;1178-1186.
47. Valentino R.J., Wehby R.G. Locus coeruleus discharge characteristics of morphine-dependent rats. Effects of naltrexone Brain Res. 488:1989;126-134.
48. Wei E., Loh H.H., Way E.L. Quantitative aspects of precipitated abstinence in morphine-dependent rats. J. Pharmacol. Exp. Ther. 184:1973;398-403.
49. Willemsen-Swinkels S.H., Buitelaar J.K., Nijhof G.J., van England H. Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies. Arch. Gen. Psychol. 52:1995;766-773.